Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.13
-0.43 (-3.42%)
May 19, 2026, 2:38 PM EDT - Market open

Kazia Therapeutics Revenue

Kazia Therapeutics had revenue of 14.66M AUD in the half year ending December 31, 2025, with 209,471,328.57% growth. This brings the company's revenue in the last twelve months to 885.77K, down -93.67% year-over-year. In the fiscal year ending June 30, 2025, Kazia Therapeutics had annual revenue of 1.83M, down -26.30%.

Revenue (ttm)
885.77K AUD
Revenue Growth
-93.67%
P/S Ratio
113.33
Revenue / Employee
147,628 AUD
Employees
6
Market Cap
138.61M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.83M-652.76K-26.30%
Jun 30, 20242.48M2.48M248,088.00%
Jun 30, 20231,000.00-24.00K-96.00%
Jun 30, 202225.00K-15.16M-99.84%
Jun 30, 202115.19M14.19M1,426.13%
Jun 30, 2020995.00K-470.43K-32.10%
Jun 30, 20191.47M-11.64M-88.82%
Jun 30, 201813.11M4.30M48.75%
Jun 30, 20178.81M4.74M116.46%
Jun 30, 20164.07M1.23M43.24%
Jun 30, 20152.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Black Diamond Therapeutics70.00M
Spero Therapeutics61.19M
Korro Bio3.84M
Alps Group3.74M
Molecular Partners AG856.30K
Spruce Biosciences697.00K
Connect Biopharma Holdings233.00K
NeOnc Technologies Holdings39.99K
Revenue Rankings

KZIA News

More News